Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

ANTXANTX
6 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in AN2 THERAPEUTICS INC

No. Janus Henderson exited its ANTX (AN2 Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 1,221,051 shares worth $2.6M. Janus Henderson first reported ANTX in Q2 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$8.6M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q2
Decreased
1.2M
-0.0%
$2.6M0.0%$2.15
0
2024-Q1
Decreased
1.2M
-4.6%
$4M0.0%$3.25
0
2023-Q4
Decreased
1.3M
-7.8%
$26.3M0.0%$20.49
0
2023-Q3
Increased
1.4M
+38.9%
$22.1M0.0%$16.08
38
2023-Q2
New
1M
-
$8.6M0.0%$8.40
38

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used